Office of In Vitro Diagnostics and Radiological Health

Results: 5



#Item
1FDA Update Office of In Vitro Diagnostics and Radiological Health (OIR) Alberto Gutierrez, Ph.D. CLIAC November 5, 2014

FDA Update Office of In Vitro Diagnostics and Radiological Health (OIR) Alberto Gutierrez, Ph.D. CLIAC November 5, 2014

Add to Reading List

Source URL: ftp.cdc.gov

Language: English - Date: 2014-11-04 20:45:46
2Regulation of Flow Cytometric In Vitro Diagnostic Devices Kevin Maher, Ph.D., DABMLI Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Regulation of Flow Cytometric In Vitro Diagnostic Devices Kevin Maher, Ph.D., DABMLI Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Add to Reading List

Source URL: www.fda.gov

Language: English
3Analytical Validation and Points for Discussion Julia Tait Lathrop, PhD Immunology and Hematology Branch Division of Immunology and Hematology Devices Office of In Vitro Diagnostics and Radiological Health

Analytical Validation and Points for Discussion Julia Tait Lathrop, PhD Immunology and Hematology Branch Division of Immunology and Hematology Devices Office of In Vitro Diagnostics and Radiological Health

Add to Reading List

Source URL: www.fda.gov

Language: English
4Strip Test, Isoniazid Classification Panel Meeting April 25, 2013 Christine King, MS, MT (ASCP) Scientific Reviewer—Chemistry and Toxicology Devices Office of In-vitro Diagnostics and Radiological Health

Strip Test, Isoniazid Classification Panel Meeting April 25, 2013 Christine King, MS, MT (ASCP) Scientific Reviewer—Chemistry and Toxicology Devices Office of In-vitro Diagnostics and Radiological Health

Add to Reading List

Source URL: www.fda.gov

Language: English
5Responsible Office/Division: Office of the Device Evaluation (ODE) Office of In Vitro Diagnostics and Radiological Health (OIR) Process Owner ODE Clinical Trials Director/OIR Chief Medical Officer

Responsible Office/Division: Office of the Device Evaluation (ODE) Office of In Vitro Diagnostics and Radiological Health (OIR) Process Owner ODE Clinical Trials Director/OIR Chief Medical Officer

Add to Reading List

Source URL: www.fda.gov

Language: English